BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2136940)

  • 1. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity.
    Specola N; Vanier MT; Goutières F; Mikol J; Aicardi J
    Neurology; 1990 Jan; 40(1):145-50. PubMed ID: 2136940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
    Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
    Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile GM2 gangliosidosis variant B1: clinical and biochemical study in seven patients.
    Maia M; Alves D; Ribeiro G; Pinto R; Sa Miranda MC
    Neuropediatrics; 1990 Feb; 21(1):18-23. PubMed ID: 2138256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B1 variant of GM2 gangliosidosis in a 12-year-old patient.
    Goebel HH; Stolte G; Kustermann-Kuhn B; Harzer K
    Pediatr Res; 1989 Jan; 25(1):89-93. PubMed ID: 2521932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
    Suzuki K; Vanier MT
    Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
    Argov Z; Navon R
    Ann Neurol; 1984 Jul; 16(1):14-20. PubMed ID: 6235771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of the B1 variant of GM2-gangliosidosis.
    Gray RG; Green A; Rabb L; Broadhead DM; Besley GT
    J Inherit Metab Dis; 1990; 13(3):280-2. PubMed ID: 2146441
    [No Abstract]   [Full Text] [Related]  

  • 8. GM2 gangliosidosis variant B1 neuroradiological findings.
    Grosso S; Farnetani MA; Berardi R; Margollicci M; Galluzzi P; Vivarelli R; Morgese G; Ballestri P
    J Neurol; 2003 Jan; 250(1):17-21. PubMed ID: 12527987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of GM2-gangliosidosis B1 variant carriers.
    Ribeiro MG; Pinto R; Oliveira P; Sá Miranda MC
    J Inherit Metab Dis; 1993; 16(6):1003-11. PubMed ID: 8127050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive dystonia symptomatic of juvenile GM2 gangliosidosis.
    Nardocci N; Bertagnolio B; Rumi V; Angelini L
    Mov Disord; 1992; 7(1):64-7. PubMed ID: 1532632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
    Praamstra P; Wevers RA; Gabreëls FJ; Rotteveel JJ; Renier WO; Sengers RC; Lamers KJ
    Clin Neurol Neurosurg; 1990; 92(2):143-8. PubMed ID: 2163796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases.
    Willner JP; Grabowski GA; Gordon RE; Bender AN; Desnick RJ
    Neurology; 1981 Jul; 31(7):787-98. PubMed ID: 6454083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tay-Sachs disease: B1 variant.
    Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
    Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; Macías-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review.
    Adams C; Green S
    Dev Med Child Neurol; 1986 Apr; 28(2):236-43. PubMed ID: 2940136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric aspects of adult-onset Tay-Sachs disease: two case reports with several new findings.
    Hurowitz GI; Silver JM; Brin MF; Williams DT; Johnson WG
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):30-6. PubMed ID: 8428133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
    Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
    Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
    Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
    Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.